Trademark: 97777914
Word
CANCERVAX
Status Date
Tuesday, April 2, 2024
Registration Number
7349127
Registration Date
Tuesday, April 2, 2024
Filing Date
Thursday, February 2, 2023
42 Pharmaceutical drug development services; Pharmaceutical research services; Providing information about medical research in the field of cancer, pharmaceutical drugs, cancer risks, and Immunotherapy
The mark consists of stylized text CANCERVAX.
Color is not claimed as a feature of the mark.
Apr 2, 2024
Notice Of Registration Confirmation Emailed
Apr 2, 2024
Registered-Supplemental Register
Feb 26, 2024
Approved For Registration Supplemental Register
Feb 7, 2024
Teas/Email Correspondence Entered
Feb 6, 2024
Correspondence Received In Law Office
Feb 6, 2024
Teas Response To Office Action Received
Nov 13, 2023
Notification Of Non-Final Action E-Mailed
Nov 13, 2023
Non-Final Action E-Mailed
Nov 13, 2023
Non-Final Action Written
Oct 31, 2023
Assigned To Examiner
Feb 21, 2023
New Application Office Supplied Data Entered
Feb 7, 2023
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24